APA (7th ed.) Citation

Le, D. T., Brockstedt, D. G., Nir-Paz, R., Hampl, J., Mathur, S., Nemunaitis, J., . . . Laheru, D. A. (2012). A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: Phase I studies of safety and immune induction. Clinical cancer research, 18(3), 858. https://doi.org/10.1158/1078-0432.CCR-11-2121

Chicago Style (17th ed.) Citation

Le, Dung T., et al. "A Live-attenuated Listeria Vaccine (ANZ-100) and a Live-attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction." Clinical Cancer Research 18, no. 3 (2012): 858. https://doi.org/10.1158/1078-0432.CCR-11-2121.

MLA (9th ed.) Citation

Le, Dung T., et al. "A Live-attenuated Listeria Vaccine (ANZ-100) and a Live-attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction." Clinical Cancer Research, vol. 18, no. 3, 2012, p. 858, https://doi.org/10.1158/1078-0432.CCR-11-2121.